US Stocks
/
Compass Therapeutics, Inc. Share Price

Compass Therapeutics, Inc. Share Price

NASDAQ: CMPX | Micro Cap
$0.99
-$0.02 (-1.85%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Compass Therapeutics, Inc. Stock Performance

Open
$1.01
Prev. Close
$1.01
Circuit Range
N/A
Day Range
$0.96 - $1.01
Year Range
$0.83 - $6.86
Volume
1,49,176
Average Traded
$0.98

Compass Therapeutics, Inc. Share Price Today

As of 9 October 2026, Compass Therapeutics, Inc.'s share price is $0.99. The stock opened at $1.01, compared to its previous close of $1.01. During today's trading session, Compass Therapeutics, Inc.'s share price traded between $0.96 and $1.01, with an average price of $0.98. Over the past 52 weeks, the stock has recorded a high of $6.86 and a low of $0.83. In terms of performance, Compass Therapeutics, Inc.'s share price has declined by 44.31% over the last six months and is down 73.46% on a year-on-year basis.

Compass Therapeutics, Inc. Share Price Chart

$0.96$1.01
L
Show Current Price
H

Compass Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$156.32M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.41
Revenue (TTM)
$0.00
Return On Equity (TTM)
-44.23%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-76.37%

Compass Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$14.26-$15.72-$18.32-$25.15
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-10.24%-16.54%-37.28%

Compass Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.85$0.00
Net Profit-$39.23-$42.49-$49.38-$66.49
Net Profit MarginN/AN/A-5809.41%N/A
Income ChangeN/A-8.31%-16.22%-34.65%

About Compass Therapeutics, Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Compass Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.02
$0.99
-4.64%
Sep 2026
$2.36
$1.03
-59.01%
Aug 2026
$1.93
$2.52
+32.55%
Jul 2026
$2.19
$1.91
-12.81%
Jun 2026
$2.30
$2.19
-8.77%
May 2026
$1.78
$2.40
+34.55%
Apr 2026
$5.43
$1.78
-66.35%
Mar 2026
$5.38
$5.29
-6.21%
Feb 2026
$6.41
$5.64
-11.81%
Jan 2026
$5.36
$6.39
+19.09%
Dec 2025
$5.83
$5.37
-7.33%
Nov 2025
$3.71
$5.79
+55.15%

CMPX Share Price FAQs

What is Compass Therapeutics, Inc. share price today?

chevron-up
Compass Therapeutics, Inc. share price today is $0.99 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Compass Therapeutics, Inc. stock?

chevron-up
The 52 week high of Compass Therapeutics, Inc. stock is $6.86, while the 52 week low is $0.83 as of 9 Oct '26.

What is CMPX's market capitalisation today?

chevron-up
CMPX market capitalisation is $156.32M as of October 9, 2026, at 4:04 am IST.

What is CMPX's net income for the last quarter?

chevron-up
CMPX's net income for the last quarter is -25.15B USD.

What is the 5 year returns of CMPX?

chevron-up
The 5 year returns of CMPX is -69.50% as on 9 Oct '26.

What is the high & low stock price of CMPX today?

chevron-up
CMPX stock price hit a high of $1.01 and low of $0.96 as of 9 Oct '26.

Can I buy CMPX shares in India?

chevron-up
Yes. You can buy CMPX in India by opening an international trading account.